Epigenetic mechanisms are behind the regulation of the key genes associated with the osteoblastic differentiation of the mesenchymal stem cells: The role of zoledronic acid on tuning the epigenetic changes. Issue 9 (16th January 2019)

• Record Type: Journal Article
• Authors: Marofi, Faroogh; Hassanzadeh, Ali; Solali, Saeed; Vahedi, Ghasem; Mousavi Ardehaie, Reza; Salarinasab, Sadegh; Aliparasti, Mohammad Reza; Ghaebi, Mahnaz; Farshdousti Hagh, Majid
• Is Part Of: Journal of cellular physiology. Volume 234:Issue 9(2019:Sep.)
• Page Start: 15108
• Page End: 15122
• Publication Date: 2019-01-16
• Subjects: DNA methylation -- epigenetic mechanism -- mesenchymal stem cells -- osteogenesis -- zoledronic acid; Physiology -- Periodicals; Cell physiology -- Periodicals; 571.6
• DOI: 10.1002/jcp.28152
• Languages: English
• ISSNs: 0021-9541

Abstract

Abstract: Mesenchymal stem cells (MSCs) are multipotent stem cells and show distinct features such as capability for self‐renewal and differentiation into several lineages of cells including osteoblasts, chondrocytes, and adipocytes. In this study, the methylation status of the promoter region of zinc finger and BTB domain containing 16 (ZBTB16), twist‐related protein 1(Twist1), de novo DNA methyltransferases 3A (DNMT3A), SRY‐box 9 (Sox9), osteocalcin (OCN), and peroxisome proliferator‐activated receptor γ2 (PPARγ2) genes and their messenger RNA (mRNA) expression levels were evaluated during the osteoblastic differentiation of MSCs (ODMSCs). We planned two experimental groups including zoledronic acid (ZA)‐treated and nontreated cells (negative control) which both were differentiated into the osteoblasts. Methylation level of DNA in the promoter regions was assayed by methylation‐specific‐quantitative polymerase chain reaction (MS‐qPCR), and mRNA levels of the target inhibitory/stimulatory genes during osteoblastic differentiation of MSCs were measured using real‐time PCR. During the experimental induction of ODMSCs, the mRNA expression of the OCN gene was upregulated and methylation level of its promoter region was decreased. Moreover, Sox9 and PPARγ2 mRNA levels were attenuated and their promoter regions methylation levels were significantly augmented. However, the mRNA expression of the DNMT3A was not affected during the ODMSCs though its methylation rate was increased. In addition, ZA could enhance the expression of the ZBTB16 and decrease its promoter regions methylation and on the opposite side, it diminished mRNA expression of Sox9, Twist1, and PPARγ2 genes and increased their methylation rates. Intriguingly, ZA did not show a significant impact on gene expression and methylation levels the OCN and DNMT3A. We found that methylation of the promoter regions of Sox9, OCN, and PPARγ2 genes might be one of the main mechanisms adjusting the genes expression during the ODMSCs. Furthermore, we noticed that ZA can accelerate the MSCs differentiation to the osteoblast cells via two regulatory processes; suppression of osteoblastic differentiation inhibitor genes including Sox9, Twist1, and PPARγ2, and through promotion of the ZBTB16 expression. Abstract : Mesenchymal stem cells (MSCs) are multipotent stem cells and show distinct features such as capability for self‐renewal and differentiation into several lineages of cells including osteoblasts, chondrocytes, and adipocytes. In this study, the methylation status of the promoter region of zinc finger and BTB domain containing 16 (ZBTB16), twist‐related protein 1(Twist1), de novo DNA methyltransferases 3A (DNMT3A), SRY‐box 9 (Sox9), osteocalcin (OCN), and peroxisome proliferator‐activated receptor γ2 (PPARγ2) genes and their messenger RNA (mRNA) expression levels were evaluated during the osteoblastic differentiation of MSCs (ODMSCs).